540 results C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here. The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement. RIE vs. CSRD: rapportageverplichtingen voor industriële bedrijven In deze Stibbe Legal Insights leggen we de rapportageverplichtingen uit de herziene Richtlijn Industriële Emissies naast die van de Corporate Sustainability Reporting Directive. Industriële bedrijven krijgen met beide te maken. Tom Verdonk Associate Amsterdam Céline Groen Senior Associate Amsterdam Ali al Khatib Senior Associate Amsterdam Stibbe advises Seven2 Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek. Commission publishes PSD3 and PSR Proposal; a tightening of the regulation of payment services providers in the EU On June 28, 2023, the European Commission published a set of new legislative proposals, including PSD3, aimed at ushering in the digital era for payments and the broader financial sector, with a particular focus on consumers. Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network. The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests. Extended access to electronic data for the Belgian Competition Authority The Belgian legislator has amended some competition law provisions in Book IV Code of Economic law. The new provision on access to data of electronic communications operators endows the Belgian Competition Authority with new investigation powers. Omnibus I: clarity on the future of the CSRD and CSDDD The long-awaited clarity on Omnibus I is here: the European Parliament and the Council of the European Union have reached a political agreement on the text. The European Parliament has already adopted the text, and for the Council of the European Union th Omnibus I: duidelijkheid over de toekomst van de CSRD en CSDDD De lang verwachte duidelijkheid over Omnibus I is er, het Europees Parlement en de Raad van de Europese Unie hebben een politiek akkoord bereikt de tekst. Het Europees Parlement heeft de tekst al aangenomen, en voor de Raad van de Europese Unie lijkt dit EU ESG wrap-up: concluding 2025 and stepping into 2026 In this blog, we briefly discuss the notable legal developments of 2025 and describe some of the major EU legal and legislative developments expected in 2026 and the planned proposals from the European Commission (EC) work programme for 2026. Upward referral of killer acquisitions: enlightened or one-stop shop flop? Companies involved in M&A deals falling below the EU and national notification thresholds need to think twice about their deal’s potential impact on competition from now on. Pagination Previous page Page 23 Current page 24 Page 25 Page 26 Next page
C'est le ton qui fait la musique – The end of employer copyrights? The CJEU decision in the National Orchestra of Belgium decision shakes up employer copyright in the Netherlands. With new consent and compensation requirements, are your employment contracts still airtight? Discover the implications of the decision here.
The long and (un)winding road of ‘killer acquisition’ Illumina/Grail Crystal ball gazing into prospective innovation rat races when assessing vertical mergers may soon be all in a day’s work for the European Commission. Innovation was a recurring theme in the Commission’s handling of the Illumina/Grail deal.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Commission steers market definition to the 21st century Companies have a new and improved tool for the competitive assessment of their conduct and intended acquisitions. The European Commission has updated its guidance on how to define relevant markets for the purpose of EU competition law enforcement.
RIE vs. CSRD: rapportageverplichtingen voor industriële bedrijven In deze Stibbe Legal Insights leggen we de rapportageverplichtingen uit de herziene Richtlijn Industriële Emissies naast die van de Corporate Sustainability Reporting Directive. Industriële bedrijven krijgen met beide te maken.
Stibbe advises Seven2 Stibbe advised Seven2 on the acquisition of a majority stake in Zwart Techniek.
Commission publishes PSD3 and PSR Proposal; a tightening of the regulation of payment services providers in the EU On June 28, 2023, the European Commission published a set of new legislative proposals, including PSD3, aimed at ushering in the digital era for payments and the broader financial sector, with a particular focus on consumers.
Belgian Competition Authority confirms jurisdiction for M&A transactions in hospital sector On 14 July 2023, the Belgian Competition Authority confirmed its jurisdiction to review M&A transactions between hospitals, regardless of whether these hospitals belong to the same hospital network.
The era of FDI screenings kicks off in Belgium The Belgian screening mechanism for FDIs will enter into force on 1 July 2023. The mechanism is designed to safeguard Belgium's critical infrastructure and to protect sectors crucial to Belgium's public order, national security and strategic interests.
Extended access to electronic data for the Belgian Competition Authority The Belgian legislator has amended some competition law provisions in Book IV Code of Economic law. The new provision on access to data of electronic communications operators endows the Belgian Competition Authority with new investigation powers.
Omnibus I: clarity on the future of the CSRD and CSDDD The long-awaited clarity on Omnibus I is here: the European Parliament and the Council of the European Union have reached a political agreement on the text. The European Parliament has already adopted the text, and for the Council of the European Union th
Omnibus I: duidelijkheid over de toekomst van de CSRD en CSDDD De lang verwachte duidelijkheid over Omnibus I is er, het Europees Parlement en de Raad van de Europese Unie hebben een politiek akkoord bereikt de tekst. Het Europees Parlement heeft de tekst al aangenomen, en voor de Raad van de Europese Unie lijkt dit
EU ESG wrap-up: concluding 2025 and stepping into 2026 In this blog, we briefly discuss the notable legal developments of 2025 and describe some of the major EU legal and legislative developments expected in 2026 and the planned proposals from the European Commission (EC) work programme for 2026.
Upward referral of killer acquisitions: enlightened or one-stop shop flop? Companies involved in M&A deals falling below the EU and national notification thresholds need to think twice about their deal’s potential impact on competition from now on.